JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALEX
1726
DELISTED
Alexander & Baldwin
ALEX
| $15M | ﹤0.01% |
716,351
+93,583
| +15% | +$2.12M |
|
1727
CALL
RTX Corp
RTX
$298B
| $15M | ﹤0.01% |
158,900
-214,515
| -57% | -$19.5M |
|
1728
CoreCivic
CXW
$3.3B
| $15M | ﹤0.01% |
860,707
-795,551
| -48% | -$12.6M |
|
|
CADE
1729
DELISTED
Cadence Bank
CADE
| $14.9M | ﹤0.01% |
475,545
-7,168
| -1% | -$221K |
|
1730
Unifirst Corp
UNF
$5.28B
| $14.9M | ﹤0.01% |
73,951
-28,758
| -28% | -$5.83M |
|
1731
PUT
Banco Bradesco
BBD
$35B
| $14.9M | ﹤0.01% |
2,220,481
+532,400
| +32% | +$3.33M |
|
1732
PUT
Intuit
INTU
$90.5B
| $14.9M | ﹤0.01% |
57,000
+50,000
| +714% | +$13.1M |
|
1733
Dana Inc
DAN
$3.2B
| $14.9M | ﹤0.01% |
819,756
-502,524
| -38% | -$8.38M |
|
1734
Liberty Latin America Class C
LILAK
$1.67B
| $14.9M | ﹤0.01% |
894,898
+282,600
| +46% | +$4.37M |
|
1735
Bio-Techne
TECH
$11.2B
| $14.9M | ﹤0.01% |
271,600
-10,856
| -4% | -$570K |
|
1736
Waters Corp
WAT
$40.7B
| $14.9M | ﹤0.01% |
63,662
-168,654
| -73% | -$37.3M |
|
|
SPR
1737
PUT
DELISTED
Spirit AeroSystems
SPR
| $14.9M | ﹤0.01% |
+203,900
| New | +$16.8M |
|
1738
W.W. Grainger
GWW
$61.6B
| $14.8M | ﹤0.01% |
43,846
-10,995
| -20% | -$3.49M |
|
1739
Iovance Biotherapeutics
IOVA
$2.96B
| $14.8M | ﹤0.01% |
535,762
+62,065
| +13% | +$1.41M |
|
1740
PUT
United Rentals
URI
$70.3B
| $14.8M | ﹤0.01% |
88,900
| – | – |
|
|
TWO
1741
Two Harbors Investment
TWO
$1.26B
| $14.8M | ﹤0.01% |
252,334
-95,528
| -27% | -$5.41M |
|
1742
PUT
Franco-Nevada
FNV
$46B
| $14.7M | ﹤0.01% |
142,500
-175,000
| -55% | -$16.9M |
|
1743
Malibu Boats
MBUU
$564M
| $14.7M | ﹤0.01% |
358,355
+683
| +0.2% | +$24.7K |
|
1744
CALL
Wells Fargo
WFC
$268B
| $14.6M | ﹤0.01% |
271,700
-397,900
| -59% | -$20.8M |
|
1745
Ashland
ASH
$3.41B
| $14.6M | ﹤0.01% |
190,857
+47,792
| +33% | +$3.63M |
|
1746
CRISPR Therapeutics
CRSP
$5.2B
| $14.5M | ﹤0.01% |
238,629
+234,025
| +5,083% | +$12.8M |
|
1747
Crane NXT
CXT
$2.95B
| $14.5M | ﹤0.01% |
483,249
-75,073
| -13% | -$2.14M |
|
1748
Ingredion
INGR
$6.54B
| $14.5M | ﹤0.01% |
155,679
-54,604
| -26% | -$4.59M |
|
1749
CONMED
CNMD
$1.48B
| $14.5M | ﹤0.01% |
129,383
+12,488
| +11% | +$1.33M |
|
1750
Essential Utilities
WTRG
$11.4B
| $14.4M | ﹤0.01% |
307,829
-151,578
| -33% | -$6.83M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.